Skip to main content
Erschienen in: Critical Care 1/2021

Open Access 01.12.2021 | COVID-19 | Research Letter

Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID‑19 associated acute respiratory distress syndrome

verfasst von: Sergey N. Avdeev, Galina V. Nekludova, Natalia V. Trushenko, Natalia A. Tsareva, Andrey I. Yaroshetskiy, Djuro Kosanovic

Erschienen in: Critical Care | Ausgabe 1/2021

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
PP
Prone position
ARDS
Acute respiratory distress syndrome
PaO2
Partial pressure of oxygen
FiO2
Fraction of inspired oxygen
PaCO2
Arterial carbon dioxide tension
SpO2
Oxygen saturation
CPAP
Continuous positive airway pressure
RR
Respiratory rate
HR
Heart rate
LUS
Lung ultrasound
To the Editor,
Prone positioning (PP) is a well-known therapeutic strategy used in acute respiratory distress syndrome (ARDS). Several studies demonstrated positive effects of PP on oxygenation parameters in awake non-intubated patients with COVID-19-associated ARDS [13]. However, PP is not effective in every case. The pilot study by Elharrar et al. demonstrated a significant improvement of oxygenation parameters during PP in only 25% of the patients [3]. The results of previous studies highlighted heterogeneity of COVID-19-associated ARDS, which demands further studies of the predictors of PP effectiveness and indications for its use in COVID-19 patients. The main objective of our study was to evaluate whether the changes of lung aeration assessed by lung ultrasound (LUS) can predict the oxygenation response during PP.
This prospective cohort study was conducted in COVID-19 care units of two university-affiliated hospitals (Sechenov University) between April 8 and May 10, 2020. The study included spontaneously breathing patients with confirmed or suspected diagnosis of COVID-19, and bilateral changes detected by high-resolution computed tomography and PaO2/FiO2 < 300 mmHg.
The study included 22 COVID-19 patients. Median age was 48.5 (39.8–62.8) years, 16 were male, and the median body mass index was 28.7 (27.3–31.6)kg/m2. The main co-morbidities were arterial hypertension (31.8%) and diabetes mellitus (18.2%). Sixteen patients (72.7%) received CPAP and 6 patients (27.3%) received oxygen therapy.
Sixteen of 22 patients (72.7%) responded to PP treatment with significant increase in PaO2/FiO2. At the same time, fewer patients had clinically significant improvement in dyspnea score—3 patients (13.6%) at 15 min in PP and 12 patients (54.5%) at 3 h in PP (Table 1). RR also significantly improved in responders.
Table 1
Comparison of changes over time in respiratory variables in responders and non-responders
Parameters
Non-responders
Responders
p value
LUS (total aeration) score, baseline
18.5 (16.0–20.3)
17.5 (17.0–20.8)
0.97
LUS (total aeration) score, PP at 3 h
16.0 (14.5–18.8)
13.5 (12.3–14.0)
0.03
LUS (posterior segments) score, baseline
6.0 (4.3–7.3)
8.5 (7.3–9.8)
0.006
LUS (posterior segments) score, PP at 3 h
5.5 (4.0–6.0)
4.0 (4.0–5.0)
0.20
LUS (anterior segments) score, baseline
6.0 (5.3–7.5)
5.0 (4.0–5.0)
0.05
LUS (anterior segments) score, PP at 3 h
6.5 (4.3–7.3)
5.0 (4.0–6.0)
0.11
LUS (lateral segments) score, baseline
6.0 (4.8–7.5)
5.5 (4.0–6.0)
0.37
LUS (lateral segments) score, PP at 3 h
5.0 (4.5–7.3)
4.0 (3.0–5.0)
0.07
PaO2/FiO2 at baseline
138 (113–177)
136 (118–172)
0.53
PaO2/FiO2 PP at 3 h
148 (128–182)
181 (174–210)
0.03
PaCO2 at baseline
36 (34–41)
37 (34–40)
0.94
PaCO2 PP at 3 h
36 (34–40)
37 (35–38)
0.92
SpO2/FiO2 at baseline
181 (176–228)
180 (177–211)
0.86
SpO2/FiO2 PP at 15 min
183 (178–230)
190 (188–222)
0.07
SpO2/FiO2 PP at 3 h
185 (178–224)
194 (193–233)
0.07
SpO2/FiO2 supine at 15 min
182 (179–226)
188 (184–227)
0.08
SpO2/FiO2 supine at 1 h
179 (176–226)
184 (182–215)
0.13
RR at baseline
23 (22–26)
24 (20–26)
0.91
RR PP at 15 min
22 (19–26)
21 (20–24)
0.65
RR PP at 3 h
21 (18–27)
19 (16–21)
0.08
RR supine at 15 min
23 (22–26)
20 (18–23)
0.02
RR supine at 1 h
24 (22–26)
23 (18–25)
0.29
HR at baseline
79 (72–93)
81 (79–94)
0.24
HR PP at 15 min
91 (73–100)
88 (76–98)
0.12
HR PP at 3 h
85 (79–97)
74 (70–91)
0.20
HR supine at 15 min
81 (76–88)
89 (80–97)
0.88
HR supine at 1 h
86 (75–104)
79 (74–88)
0.37
Dyspnea Borg at baseline
5 (3–6)
5 (3–6)
0.89
Dyspnea Borg PP at 15 min
4 (2–6)
4 (2–6)
0.95
Dyspnea Borg PP at 3 h
5 (3–7)
3 (2–4)
0.26
Dyspnea Borg supine at 15 min
4 (3–6)
3 (2–6)
0.43
Dyspnea Borg supine at 1 h
5 (4–6)
4 (2–5)
0.12
The study protocol included the measurement of SpO2, respiratory rate (RR), heart rate (HR) and dyspnea assessment using Borg-Dyspnea-Scale (at baseline, after 15 min in PP, after 3 h in PP, 15 min and 1 h after turning in supine position). Arterial blood gas analysis was measured twice: at baseline and after 3 h in PP. The increase of PaO2/FiO2 by 20 mmHg in 3 h after turning a patient into the prone position was used as the criterion of the response to PP. All parameters of respiratory support and FiO2 were the same during supine and prone positions. Before PP and after 3 h in PP semi-quantitative assessment of the lung tissue was performed by LUS. The study protocol included 14 areas for scanning (two anterior, two lateral and three posterior regions of each hemithorax) [4]
Data are expressed as median (inter-quartile range). PaO2/FiO2 (mmHg): arterial oxygen tension to inspired oxygen fraction ratio; PaCO2 (mmHg): arterial carbon dioxide tension; SpO2/FiO2: arterial oxygen saturation to inspired oxygen fraction ratio; RR (min−1): respiratory rate, HR (min−1): heart rate; LUS: lung ultrasound; PP: prone position
Responders and non-responders demonstrated significant differences in disease duration (8.5 (5.0–10.8) vs. 13.0 (10.0–17.0) days of disease, p = 0.02), no other differences in baseline clinical and laboratory parameters were observed. Three patients (all from non-responder group) were transferred to intensive care unit and then intubated, two of them died.
The patients who responded to PP had more pronounced disturbances of aeration in posterior regions (8.5 (7.3–9.8) vs. 6.0 (4.3–7.3); p = 0.006) as reflected by greater LUS. The decrease of the total LUS score and LUS score of posterior regions was significantly greater in responders (5.0 (4.0–7.0) vs. 1.5 (1.0–3.0); p < 0.005 and 4.0 (3.5–5.0) vs. 1.0 (0.0–1.0); p < 0.001, respectively). The area under the receiver operating characteristic curve of posterior LUS score for the oxygenation response during PP was 0.87 (95% CI 0.64–1.0; p < 0.01). Changes of aeration score over time in posterior segments by LUS data correlated with PaO2/FiO2 changes (r = 0.53, p = 0.01), i.e. aeration improvement in posterior lung segments was associated with improved oxygenation status (Fig. 1).
Previous studies examined the changes of aeration by LUS in PP in intubated patients with ARDS not-associated with COVID-19 [5, 6]. Haddam et al. found that oxygenation response to PP was not correlated with a specific LUS pattern regardless of the focal or non-focal nature of ARDS [5]. However, Wang et al. demonstrated that aeration score changes assessed by LUS were significantly higher in the PP responder and survivor groups [6]. Our study demonstrated in awake non-intubated patients with COVID-19-associated ARDS the relationship between the pattern of lung changes (presence of areas with subpleural consolidations), their localization (posterior segments) as shown by LUS, and the response to PP.
In conclusion, in patients with severe COVID-19, response to PP probably depends on the extent and localization of lung tissue changes. The aeration changes assessed by LUS may be useful in prediction of oxygenation response to PP in awake non-intubated patients with COVID‑19‑associated ARDS.

Acknowledgements

None.
The local ethics committee (LEC No. 16-2016-20) approved the study. The ethics committee of the hospitals (Sechenov First Moscow State Medical University) waived the written informed consent from patients with COVID-19, and all the procedures being performed were part of the routine care.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
4.
Zurück zum Zitat Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF, et al. Proposal for international standardization of the use of lung ultrasound for patients with COVID-19 patients: a simple, quantitative, reproducible method. J Ultrasound Med. 2020;39:1413–9. https://doi.org/10.1002/jum.15285.CrossRefPubMed Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF, et al. Proposal for international standardization of the use of lung ultrasound for patients with COVID-19 patients: a simple, quantitative, reproducible method. J Ultrasound Med. 2020;39:1413–9. https://​doi.​org/​10.​1002/​jum.​15285.CrossRefPubMed
Metadaten
Titel
Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID‑19 associated acute respiratory distress syndrome
verfasst von
Sergey N. Avdeev
Galina V. Nekludova
Natalia V. Trushenko
Natalia A. Tsareva
Andrey I. Yaroshetskiy
Djuro Kosanovic
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Critical Care / Ausgabe 1/2021
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-021-03472-1

Weitere Artikel der Ausgabe 1/2021

Critical Care 1/2021 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Schlaganfall: frühzeitige Blutdrucksenkung im Krankenwagen ohne Nutzen

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.